| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NMI HLDGS INC CL A | 7,371,500 | 56,023,000 | 25.86% | ||
| 2 | YPF SOCIEDAD ANONIMA SPON ADR CL D | 2,250,000 | 34,268,000 | 15.82% | Call | |
| 3 | IMPAX LABORATORIES INC | 606,618 | 21,359,000 | 9.86% | ||
| 4 | CF INDS HLDGS INC | 464,101 | 20,838,000 | 9.62% | ||
| 5 | GW PHARMACEUTICALS PLC | 210,715 | 19,253,000 | 8.89% | ||
| 6 | BIOMARIN | 129,501 | 13,639,000 | 6.30% | ||
| 7 | VERTEX PHARMACEUT | 100,000 | 10,414,000 | 4.81% | ||
| 8 | DBV TECHNOLOGIES | 265,376 | 9,445,000 | 4.36% | ||
| 9 | ProNAi Therapeutics, Inc. | 422,200 | 8,664,000 | 4.00% | ||
| 10 | ECO STIM ENERGY SOLUTIONS IN | 2,130,000 | 7,306,000 | 3.37% | ||
| 11 | ALLERGAN PLC | 17,813 | 4,842,000 | 2.23% | ||
| 12 | ALCOBRA LTD | 625,792 | 3,780,000 | 1.74% | ||
| 13 | ENDO INTL | 52,634 | 3,647,000 | 1.68% | ||
| 14 | MYLAN N V | 78,905 | 3,177,000 | 1.47% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011999, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
